title: Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen.
abstract: In 212 postmenopausal women with node-positive oestrogen receptor-positive (ER(LBA)) breast cancer subjected to radical surgery and adjuvant tamoxifen, the risk of 6-year relapse increased with increasing values of intratumoral vascular endothelial growth factor (VEGF) in patients whose tumours had a low/intermediate ER(LBA) content compared to patients with high-ER(LBA) tumours. These findings indicate that tumour progression, activated or sustained by high VEGF levels, may be counteracted in high-ER(LBA) cancers by tamoxifen, which in contrast fails to contrast the metastatic potential in low-ER(LBA) tumours.
authors.affiliation: Unità Operativa Determinanti Biomolecolari nella Prognosi e Terapia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian, 1, 20133 Milan, Italy. danila.coradini@istitutotumori.mi.it
authors.forename: D
authors.initials: D
authors.lastname: Coradini
authors.forename: E
authors.initials: E
authors.lastname: Biganzoli
authors.forename: C
authors.initials: C
authors.lastname: Pellizzaro
authors.forename: S
authors.initials: S
authors.lastname: Veneroni
authors.forename: S
authors.initials: S
authors.lastname: Oriana
authors.forename: F
authors.initials: F
authors.lastname: Ambrogi
authors.forename: R
authors.initials: R
authors.lastname: Erdas
authors.forename: P
authors.initials: P
authors.lastname: Boracchi
authors.forename: M G
authors.initials: MG
authors.lastname: Daidone
authors.forename: E
authors.initials: E
authors.lastname: Marubini
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000503:physiopathology* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D018450:Disease Progression; D016228:Endothelial Growth Factors / Q000097:blood*; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D008207:Lymphatic Metastasis; D008222:Lymphokines / Q000097:blood*; D008408:Mastectomy; D008875:Middle Aged; D017698:Postmenopause; D011237:Predictive Value of Tests; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis*; D012307:Risk Factors; D013629:Tamoxifen / Q000008:administration & dosage / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D011960:Receptors, Estrogen; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D013629:Tamoxifen